Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.92M Buy
34,605
+14,189
+69% +$1.41M 0.01% 870
2026
Q1
$1.92M Buy
20,416
+7,292
+56% +$728K 0.01% 1131
2025
Q4
$1.3M Buy
13,124
+2,299
+21% +$222K ﹤0.01% 1330
2025
Q3
$918K Buy
10,825
+919
+9% +$72.6K ﹤0.01% 1442
2025
Q2
$675K Sell
9,906
-2,691
-21% -$170K ﹤0.01% 1521
2025
Q1
$763K Buy
12,597
+9,913
+369% +$691K ﹤0.01% 1341
2024
Q4
$185K Sell
2,684
-4,288
-62% -$306K ﹤0.01% 2106
2024
Q3
$461K Sell
6,972
-16,115
-70% -$1.03M ﹤0.01% 1522
2024
Q2
$1.4M Buy
23,087
+4,456
+24% +$252K 0.01% 912
2024
Q1
$1.06M Buy
18,631
+18,532
+18,719% +$1.11M 0.01% 974
2023
Q4
$6.22K Buy
+99
New +$5.6K ﹤0.01% 3049
2023
Q1
Sell
-8,353
Closed -$671K 3777
2022
Q4
$671K Buy
+8,353
New +$639K 0.02% 663

Other funds holding INCY

NewEdge Advisors's INCY Position: Q2 2026 in Review

NewEdge Advisors increased its Incyte (INCY) stake by 69% in Q2 2026, buying an estimated $1.41M and bringing the position to 34,605 shares worth $3.92M. The position accounts for 0.01% of the portfolio, ranked #870.

NewEdge Advisors first reported a position in INCY in Q4 2022 and has held it in 12 quarters since. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • NewEdge Advisors held 34,605 shares of Incyte worth $3.92M as of Q2 2026.
  • NewEdge Advisors bought 14,189 Incyte shares in Q2 2026, an estimated $1.41M.
  • Incyte made up 0.01% of NewEdge Advisors's portfolio in Q2 2026, its #870 holding.
  • NewEdge Advisors first reported a position in Incyte in Q4 2022 and has held it in 12 quarters since.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.